Advertisement

Endogenous carboxyhemoglobin concentrations in the assessment of severity in patients with community-acquired pneumonia

Published:December 07, 2012DOI:https://doi.org/10.1016/j.ajem.2012.10.005

      Abstract

      Introduction

      Previous studies have shown that carbon monoxide, which is endogenously produced, is increased in community-acquired pneumonia (CAP). However, it has not been studied enough whether severity of pneumonia is correlated with increased carboxyhemoglobin (COHb) concentrations in CAP. The aim of this study was to determine whether endogenous carbon monoxide levels in patients with CAP were higher compared with the control group and, if so, to determine whether COHb concentrations could predict severity in CAP.

      Materials and methods

      Eighty-two patients with CAP were evaluated in this cross-sectional study during a 10-month period. Demographic data, pneumonia severity index and confusion, uremia, rate respiratory, pressure blood, age>65 (CURB-65) scores, hospital admission or discharge decisions, and 30-day hospital mortality rate were recorded. In addition, 83 control subjects were included to study. The COHb concentration was measured in arterial blood sample.

      Results

      The levels of COHb in patients with CAP were 1.70% (minimum-maximum, 0.8-3.2), whereas those in control subjects, 1.40% (minimum-maximum, 0.8-2.9). The higher COHb concentrations in patients with CAP were statistically significant (P < .05). Concentration of COHb correlated with pneumonia severity index (P = .04, r = 0.187); however, it did not correlate with CURB-65 (P = .218, r = 0.112).

      Conclusion

      Although COHb concentrations show an increase in patients with pneumonia, it was concluded that this increase did not act as an indicator in diagnosis process or prediction of clinical severity for the physicians.
      To read this article in full you will need to make a payment
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to The American Journal of Emergency Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Pimentel L.
        • McPherson S.J.
        Community-acquired pneumonia in the emergency department: a practical approach to diagnosis and management.
        Emerg Med Clin North Am. 2003; 21: 395-420
        • Maines M.D.
        • Kappas A.
        Cobalt induction of hepatic heme oxygenase; with evidence that cytochrome P-450 is not essential for this enzyme activity.
        Proc Natl Acad Sci USA. 1974; 71: 4293-4297
        • Maines M.D.
        • Trakshel G.M.
        • Kutty R.K.
        Characterization of two constitutive forms of rat liver microsomal heme oxygenase. Only one molecular species of the enzyme is inducible.
        J Biol Chem. 1986; 261: 411-419
        • McCoubrey Jr., W.K.
        • Huang T.J.
        • Maines M.D.
        Isolation and characterization of a cDNA from the rat brain that encodes hemoprotein heme oxygenase-3.
        Eur J Biochem. 1997; 247: 725-732
        • Lee P.J.
        • Camhi S.L.
        • Chin B.Y.
        • Alam J.
        AP-1 and STAT mediate hyperoxia-induced gene transcription of heme oxygenase-1.
        Am J Physiol Lung Cell Mol Physiol. 2000; 279: L175-L182
        • Donnelly L.E.
        • Barnes P.J.
        Expression of heme oxygenase in human airway epithelial cells.
        Am J Respir Cell Mol Biol. 2001; 24: 295-303
        • Li N.
        • Venkatesan M.I.
        • Miguel A.
        • et al.
        Induction of heme oxygenase-1 expression in macrophages by diesel exhaust particle chemicals and quinones via the antioxidant-responsive element.
        J Immunol. 2000; 165: 3393-3401
        • Yasuda H.
        • Yamaya M.
        • Yanai M.
        • et al.
        Increased blood carboxyhaemoglobin concentrations in inflammatory pulmonary diseases.
        Thorax. 2002; 57: 779-783
        • Yasuda H.
        • Sasaki T.
        • Yamaya M.
        • et al.
        Increased arteriovenous carboxyhemoglobin differences in patients with inflammatory pulmonary diseases.
        Chest. 2004; 125: 2160-2168
        • Fine M.J.
        • Auble T.E.
        • Yealy D.M.
        • et al.
        A prediction rule to identify low-risk patients with community-acquired pneumonia.
        N Engl J Med. 1997; 336: 243-250
        • Lim W.S.
        • Van Der Eerden M.
        • Laing R.
        • et al.
        Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study.
        Thorax. 2003; 58: 377-382
        • Tenhunen R.
        • Marver H.S.
        • Schmid R.
        Microsomal heme oxygenase: characterization of the enzyme.
        J Biol Chem. 1969; 244: 6388-6394
        • Tenhunen R.
        • Marver H.S.
        • Schmid R.
        The enzymatic conversion of heme to bilirubin by microsomal hemeoxygenase.
        Proc Natl Acad Sci USA. 1968; 61: 748-755
        • Paredi P.
        • Shah P.L.
        • Montuschi P.
        • et al.
        Increased carbonmonoxide in exhaled air of patients with cystic fibrosis.
        Thorax. 1999; 54: 917-920
        • Yamara M.
        • Sekizawa K.
        • Ishizuka S.
        • et al.
        Exhaled carbon monoxide levels during treatment of acute asthma.
        Eur Respir J. 1999; 13: 757-760
        • Yasuda H.
        • Yamaya M.
        • Nakayama K.
        • et al.
        Increased arterial carboxyhemoglobin concentrations in chronic obstructive pulmonary disease.
        Am J Respir Crit Care Med. 2005; 171: 1246-1251
        • Chalmers J.D.
        • Singanayagam A.
        • Hill A.T.
        C-reactive protein is an independent predictor of severity in community-acquired pneumonia.
        Am J Med. 2008; 121: 219-225
        • De Siqueira M.E.
        • Martins I.
        • Costa A.C.
        • Lima S.A.
        Reference values for carboxyhemoglobin.
        Rev Saude Publica. 1997; 31: 618-623